FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Michael Marberger

Research Profile

Disorders

Chemicals & Drugs

Concepts & Ideas

Anatomy

Prostate

Procedures

Physiology

Urodynamics

Phenomena

Microwaves

Co-author Network

Publications

TOP 3
Michael Marberger
Medical management of lower urinary tract symptoms in men with benign prostatic enlargement.
Michael Marberger; Anand Patel; Jihao Zhou; Kyu-Sung Lee; Denise Bugarin; Emmanuel Chartier-Kastler; Blair Egerdie; Joachim Grosse; Cornelia Haag-Molkenteller
A randomized double-blind placebo-controlled phase 2 dose-ranging study of onabotulinumtoxinA in men with benign prostatic hyperplasia.
Jens Hansen; Hartwig Huland; Michael Marberger; Leonard S Marks; Peter F A Mulders; Alan W Partin; Karl Pummer; Jack A Schalken; Shahrokh F Shariat; Arnulf Stenzl; Hendrik van Poppel; Jochen Walz; Clement-Claude Abbou; Sascha A Ahyai; Marco Auprich; Alberto Briganti; Alexandre de la Taille; William Ellis; Margit Fisch; Yves Fradet; Markus Graefen; Alexander Haese; fianceeyi chun
Initial prostate biopsy: development and internal validation of a biopsy-specific nomogram based on the prostate cancer antigen 3 assay.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Michael Marberger (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Michael Marberger
Medical management of lower urinary tract symptoms in men with benign prostatic enlargement.
Advances in therapy 2013;30(4):309-19.
2013: Michael Marberger; Anand Patel; Jihao Zhou; Kyu-Sung Lee; Denise Bugarin; Emmanuel Chartier-Kastler; Blair Egerdie; Joachim Grosse; Cornelia Haag-Molkenteller
A randomized double-blind placebo-controlled phase 2 dose-ranging study of onabotulinumtoxinA in men with benign prostatic hyperplasia.
European urology 2013;63(3):496-503.
2013: Jens Hansen; Hartwig Huland; Michael Marberger; Leonard S Marks; Peter F A Mulders; Alan W Partin; Karl Pummer; Jack A Schalken; Shahrokh F Shariat; Arnulf Stenzl; Hendrik van Poppel; Jochen Walz; Clement-Claude Abbou; Sascha A Ahyai; Marco Auprich; Alberto Briganti; Alexandre de la Taille; William Ellis; Margit Fisch; Yves Fradet; Markus Graefen; Alexander Haese; fianceeyi chun
Initial prostate biopsy: development and internal validation of a biopsy-specific nomogram based on the prostate cancer antigen 3 assay.
European urology 2013;63(2):201-9.
2013: Christoph Klingler; Markus Margreiter; Michael Marberger
New ablative treatments for small renal masses: HIFU ablation.
Archivos españoles de urología 2013;66(1):79-89.
2012: Tobias Klatte; Barbara Krammer; Michael Marberger; Mesut Remzi; Berthold Streubel; Martin Susani; Matthias Waldert; Friedrich Wrba; Michela de Martino; Andrea Haitel
Renal cell carcinoma associated with transcription factor E3 expression and Xp11.2 translocation: incidence, characteristics, and prognosis.
American journal of clinical pathology 2012;137(5):761-8.
2012: Michael Marberger; Francesco Montorsi; Curtis Pettaway; Roger S Rittmaster; Matthew C Somerville; Claudio Teloken; Gerald L Andriole; Mark Emberton; Stephen J Freedland; Ramiro Castro
Usefulness of prostate-specific antigen (PSA) rise as a marker of prostate cancer in men treated with dutasteride: lessons from the REDUCE study.
BJU international 2012;109(8):1162-9.
2012: Michael Marberger; Shahrokh F Shariat; Jelle Barentsz; Mark Emberton; Jonas Hugosson; Laurence Klotz; Michael Koch; Stacy Loeb; Andrew Vickers
Novel approaches to improve prostate cancer diagnosis and management in early-stage disease.
BJU international 2012;109 Suppl 2():1-7.
2012: Hein van Poppel; Mesut Remzi; Alexandre de la Taille; Theo de Reijke; Markus Graefen; Alexander Haese; Jacques Irani; Michael Marberger
The relationship between Prostate CAncer gene 3 (PCA3) and prostate cancer significance.
BJU international 2012;109(3):360-6.
2011: Klaus Aumayr; Michael Breitegger; Anke Koller; Michael Marberger; Peter R Mazal; Martin Susani; Andrea Haitel
Quantification of extraprostatic perineural spread and its prognostic value in pT3a pN0 M0 R0 prostate cancer patients.
The Prostate 2011;71(16):1790-5.
2011: Tobias Klatte; Michael Marberger
Renal cell carcinoma of native kidneys in renal transplant patients.
Current opinion in urology 2011;21(5):376-9.
2011: Michael Marberger; Timothy H Wilson; Roger S Rittmaster
Low serum testosterone levels are poor predictors of sexual dysfunction.
BJU international 2011;108(2):256-62.
2011: Michael Marberger; John D McConnell; Ivy Fowler; Gerald L Andriole; David G Bostwick; Matthew C Somerville; Roger S Rittmaster
Biopsy misidentification identified by DNA profiling in a large multicenter trial.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2011;29(13):1744-9.
2011: Michael Marberger
Is robot-assisted radical prostatectomy safer than other radical prostatectomy techniques?
European urology 2011;59(5):699-700; discussion 701.
2011: Michela de Martino; Tobias Klatte; Georg Schatzl; Matthias Waldert; Mesut Remzi; Andrea Haitel; Gero Kramer; Michael Marberger
Insertion/deletion polymorphism of angiotensin I-converting enzyme gene is linked with chromophobe renal cell carcinoma.
Urology 2011;77(4):1005.e9-1005.e13.
2011: Gerald L Andriole; David Bostwick; Otis W Brawley; Leonard G Gomella; Michael Marberger; Francesco Montorsi; Curtis A Pettaway; Teuvo L J Tammela; Claudio Teloken; Donald Tindall; Stephen J Freedland; Matthew C Somerville; Timothy H Wilson; Ivy Fowler; Ramiro Castro; Roger S Rittmaster
The effect of dutasteride on the usefulness of prostate specific antigen for the diagnosis of high grade and clinically relevant prostate cancer in men with a previous negative biopsy: results from the REDUCE study.
The Journal of urology 2011;185(1):126-31.
2010: Guillaume Ploussard; Alexander Haese; Hendrik Van Poppel; Michael Marberger; Arnulf Stenzl; Peter F A Mulders; Hartwig Huland; Laurence Bastien; Clèment-Claude Abbou; Mesut Remzi; Martina Tinzl; Susan Feyerabend; Alexander B Stillebroer; Martijn P M Q van Gils; Jack A Schalken; Alexandre de la Taille
The prostate cancer gene 3 (PCA3) urine test in men with previous negative biopsies: does free-to-total prostate-specific antigen ratio influence the performance of the PCA3 score in predicting positive biopsies?
BJU international 2010;106(8):1143-7.
2010: Markus Margreiter; Michael Marberger
Current status of open partial nephrectomy.
Current opinion in urology 2010;20(5):361-4.
2010: Tobias Klatte; Mesut Remzi; Richard Zigeuner; Sebastian Mannweiler; Jonathan W Said; Fairooz F Kabbinavar; Andrea Haitel; Matthias Waldert; Michela de Martino; Michael Marberger; Arie S Belldegrun; Allan J Pantuck
Development and external validation of a nomogram predicting disease specific survival after nephrectomy for papillary renal cell carcinoma.
The Journal of urology 2010;184(1):53-8.
2010: Michael Marberger
Editorial comment on: complications of laparoscopic and percutaneous renal cryoablation in a single tertiary referral center.
European urology 2010;58(1):147-8.
2010: Markus Margreiter; Michael Marberger
Focal therapy and imaging in prostate and kidney cancer: high-intensity focused ultrasound ablation of small renal tumors.
Journal of endourology / Endourological Society 2010;24(5):745-8.
2010: Matthias Waldert; Tobias Klatte; Jörg Schmidbauer; Mesut Remzi; Jakob Lackner; Michael Marberger
Color Doppler sonography reliably identifies testicular torsion in boys.
Urology 2010;75(5):1170-4.
2010: Tobias Klatte; Christian Seitz; Matthias Waldert; Michela de Martino; Zeljko Kikic; Georg A Böhmig; Andrea Haitel; Jörg Schmidbauer; Michael Marberger; Mesut Remzi
Features and outcomes of renal cell carcinoma of native kidneys in renal transplant recipients.
BJU international 2010;105(9):1260-5.
2010: Gerald L Andriole; David G Bostwick; Otis W Brawley; Leonard G Gomella; Michael Marberger; Francesco Montorsi; Curtis A Pettaway; Teuvo L Tammela; Claudio Teloken; Donald J Tindall; Matthew C Somerville; Timothy H Wilson; Ivy L Fowler; Roger S Rittmaster
Effect of dutasteride on the risk of prostate cancer.
The New England journal of medicine 2010;362(13):1192-202.
2010: Matthias Waldert; Tobias Klatte; Andrea Haitel; Mehmet Ozsoy; Jörg Schmidbauer; Michael Marberger; Mesut Remzi
Hybrid renal cell carcinomas containing histopathologic features of chromophobe renal cell carcinomas and oncocytomas have excellent oncologic outcomes.
European urology 2010;57(4):661-5.
2010: Michela De Martino; Tobias Klatte; Georg Schatzl; Mesut Remzi; Matthias Waldert; Andrea Haitel; Igor Stancik; Gero Kramer; Michael Marberger
Renal cell carcinoma Fuhrman grade and histological subtype correlate with complete polymorphic deletion of glutathione S-transferase M1 gene.
The Journal of urology 2010;183(3):878-83.
2010: Roman Heuer; Inderbir S Gill; Giorgio Guazzoni; Ziya Kirkali; Michael Marberger; Jerome P Richie; Jean J M C H de la Rosette
A critical analysis of the actual role of minimally invasive surgery and active surveillance for kidney cancer.
European urology 2010;57(2):223-32.
2009: Jörg Schmidbauer; Mesut Remzi; Tobias Klatte; Matthias Waldert; Julian Mauermann; Martin Susani; Michael Marberger
Fluorescence cystoscopy with high-resolution optical coherence tomography imaging as an adjunct reduces false-positive findings in the diagnosis of urothelial carcinoma of the bladder.
European urology 2009;56(6):914-9.
2009: Jakob E Lackner; Anke Koller; Georg Schatzl; Michael Marberger; Christian Kratzik
Androgen deficiency symptoms in testicular cancer survivors are associated with sexual problems but not with serum testosterone or therapy.
Urology 2009;74(4):825-9.
2009: fianceeyi chun; Alexandre de la Taille; Hendrik van Poppel; Michael Marberger; Arnulf Stenzl; Peter F A Mulders; Hartwig Huland; Clement-Claude Abbou; Alexander B Stillebroer; Martijn P M Q van Gils; Jack A Schalken; Yves Fradet; Leonard S Marks; William Ellis; Alan W Partin; Alexander Haese
Prostate cancer gene 3 (PCA3): development and internal validation of a novel biopsy nomogram.
European urology 2009;56(4):659-67.
2009: Moustafa A A El-Taieb; Ralf Herwig; Essam A Nada; Joachim Greilberger; Michael Marberger
Oxidative stress and epididymal sperm transport, motility and morphological defects.
European journal of obstetrics, gynecology, and reproductive biology 2009;144 Suppl 1():S199-203.
2009: Tobias Klatte; Michael Marberger
High-intensity focused ultrasound for the treatment of renal masses: current status and future potential.
Current opinion in urology 2009;19(2):188-91.
2009: Mesut Remzi; Michael Marberger
Renal tumor biopsies for evaluation of small renal tumors: why, in whom, and how?
European urology 2009;55(2):359-67.
2008: Michael Marberger; Peter R Carroll; Michael J Zelefsky; Jonathan Coleman; Hedvig Hricak; Peter T Scardino; Lucien L Abenhaim
New treatments for localized prostate cancer.
Urology 2008;72(6 Suppl):S36-43.
2008: Matthias Waldert; Andrea Haitel; Michael Marberger; Daniela Katzenbeisser; Mehmet Ozsoy; Elisabeth Stadler; Mesut Remzi
Comparison of type I and II papillary renal cell carcinoma (RCC) and clear cell RCC.
BJU international 2008;102(10):1381-4.
2008: Alexander Haese; Alexandre de la Taille; Hendrik van Poppel; Michael Marberger; Arnulf Stenzl; Peter F A Mulders; Hartwig Huland; Clément-Claude Abbou; Mesut Remzi; Martina Tinzl; Susan Feyerabend; Alexander B Stillebroer; Martijn P M Q van Gils; Jack A Schalken
Clinical utility of the PCA3 urine assay in European men scheduled for repeat biopsy.
European urology 2008;54(5):1081-8.
2008: Jakob E Lackner; Isabel Maerk; Anke Koller; Christian Bieglmayer; Michael Marberger; Christian Kratzik; Georg Schatzl
Serum inhibin--not a cause of low testosterone levels in hypogonadal prostate cancer?
Urology 2008;72(5):1121-4.
2008: Jakob E Lackner; Emina Lakovic; Thomas Waldhör; Georg Schatzl; Michael Marberger
Spontaneous variation of leukocytospermia in asymptomatic infertile males.
Fertility and sterility 2008;90(5):1757-60.
2008: Jörg Schmidbauer; Mesut Remzi; Mazda Memarsadeghi; Andrea Haitel; H Christoph Klingler; Daniela Katzenbeisser; Helene Wiener; Michael Marberger
Diagnostic accuracy of computed tomography-guided percutaneous biopsy of renal masses.
European urology 2008;53(5):1003-11.
2007: Jakob E Lackner; Anke Koller; Georg Schatzl; Michael Marberger; Christian Kratzik
Does histopathologic tumor type or vascular invasion influence spermatogenesis in testicular cancer?
Fertility and sterility 2007;88(5):1377-81.
2007: Jörg Schmidbauer; Michael Marberger
Recent developments in fluorescence cystoscopy: do novel agents bring a benefit?
Current opinion in urology 2007;17(5):347-51.
2007: Janet van Adelsberg; Peter H Gann; Amy T Ko; Jan-Erik Damber; Christopher Logothetis; Michael Marberger; Bernd J Schmitz-Drager; Andrea Tubaro; Celia J Harms; Claus G Roehrborn
The VIOXX in Prostate Cancer Prevention study: cardiovascular events observed in the rofecoxib 25 mg and placebo treatment groups.
Current medical research and opinion 2007;23(9):2063-70.
2007: Bob Djavan; Vincent Ravery; Bernardo Rocco; Alexandre R Zlotta; Maurizio Brausi; Markus Margreiter; Peter Hammerer; Amir Kaisary; Theodore Anagnostou; Imre Romics; Piotr Dobronski; Ottavio De Cobelli; Michael Marberger
European Study of Radical Prostatectomy: time trends in Europe, 1993-2005.
BJU international 2007;100 Suppl 2():22-5.
2007: Michael Marberger
Current prostate cancer: 20 years later.
BJU international 2007;100 Suppl 2():11-4.
2007: Bob Djavan; Bernardo Rocco; Anton Stangelberger; Ottavio De Cobelli; Michael Marberger
Is the era of prostate-specific antigen over?
BJU international 2007;100 Suppl 2():8-10.
2007: Michael Marberger
Ablation of renal tumours with extracorporeal high-intensity focused ultrasound.
BJU international 2007;99(5 Pt B):1273-6.
2007: Mesut Remzi; Daniela Katzenbeisser; Matthias Waldert; H Christoph Klingler; Martin Susani; Mazda Memarsadeghi; Gertraud Heinz-Peer; Andrea Haitel; Ralf Herwig; Michael Marberger
Renal tumour size measured radiologically before surgery is an unreliable variable for predicting histopathological features: benign tumours are not necessarily small.
BJU international 2007;99(5):1002-6.
2007: H Christoph Klingler; Michael Marberger; Julian Mauermann; Mesut Remzi; Martin Susani
'Skipping' is still a problem with radiofrequency ablation of small renal tumours.
BJU international 2007;99(5):998-1001.
2007: Michael Marberger
Energy-based ablative therapy of prostate cancer: high-intensity focused ultrasound and cryoablation.
Current opinion in urology 2007;17(3):194-9.
2007: Gero Kramer; Dieter Mitteregger; Michael Marberger
Is benign prostatic hyperplasia (BPH) an immune inflammatory disease?
European urology 2007;51(5):1202-16.
2007: Jakob E Lackner; Isabel Märk; Georg Schatzl; Michael Marberger; Christian Kratzik
Hypogonadism and androgen deficiency symptoms in testicular cancer survivors.
Urology 2007;69(4):754-8.
2007: Michael Marberger
Renal ischaemia: not a problem in laparoscopic partial nephrectomy?
BJU international 2007;99(1):3-4.
2006: Michael Marberger
Prosthetic nephrovesical bypass.
European urology 2006;50(5):879-83.
2006: Christoph H Klingler; Mesut Remzi; Michael Marberger; Günter Janetschek
Haemostasis in laparoscopy.
European urology 2006;50(5):948-56; discussion 956-7.
2006: Jörg Schmidbauer; Christian Kratzik; H Christoph Klingler; Mesut Remzi; Jakob E Lackner; Michael Marberger
Nephrovesical subcutaneous ureteric bypass: long-term results in patients with advanced metastatic disease-improvement of renal function and quality of life.
European urology 2006;50(5):1073-8; discussion 1078.
2006: Jakob E Lackner; Anke Koller; Peter R Mazal; Matthias Waldert; Thomas Waldhoer; Michael Marberger; Christian Kratzik
The changing distribution of pT stage in testicular germ cell tumours from 1976 to 2005: a single-centre analysis of histopathological reports.
BJU international 2006;98(4):747-50.
2006: Michael Marberger
Drug Insight: 5alpha-reductase inhibitors for the treatment of benign prostatic hyperplasia.
Nature clinical practice. Urology 2006;3(9):495-503.
2006: Shahrokh F Shariat; Michael Marberger; Yair Lotan; Marta Sanchez-Carbayo; Craig D Zippe; Gerson Lüdecke; Hans Boman; Ihor S Sawczuk; Martin G Friedrich; Roberto Casella; Christine Mian; Sanaa Eissa; Hideyuki Akaza; Vincenzo Serretta; Hartwig Huland; Hans Hedelin; Rupesh Raina; Naoto Miyanaga; Arthur I Sagalowsky; Claus G Roehrborn; Pierre I Karakiewicz
Variability in the performance of nuclear matrix protein 22 for the detection of bladder cancer.
The Journal of urology 2006;176(3):919-26; discussion 926.
2006: Mesut Remzi; Mehmet Ozsoy; H Christoph Klingler; Martin Susani; Matthias Waldert; Christian Seitz; Jörg Schmidbauer; Michael Marberger
Are small renal tumors harmless? Analysis of histopathological features according to tumors 4 cm or less in diameter.
The Journal of urology 2006;176(3):896-9.
2006: Jakob E Lackner; Ralf Herwig; Jörg Schmidbauer; Georg Schatzl; Christian Kratzik; Michael Marberger
Correlation of leukocytospermia with clinical infection and the positive effect of antiinflammatory treatment on semen quality.
Fertility and sterility 2006;86(3):601-5.
2006: Christian Kratzik; Georg Schatzl; Jakob E Lackner; Michael Marberger
Transcutaneous high-intensity focused ultrasonography can cure testicular cancer in solitary testis.
Urology 2006;67(6):1269-73.
2006: Christian Seitz; Harun Fajković; Mesut Remzi; Matthias Waldert; Mehmet Ozsoy; Gero Kramer; Michael Marberger
Rapid extracorporeal shock wave lithotripsy treatment after a first colic episode correlates with accelerated ureteral stone clearance.
European urology 2006;49(6):1099-105; discussion 1105-6.
2006: Michele Lodde; Christine Mian; Evi Comploj; Salvatore Palermo; Elena Longhi; Michael Marberger; Armin Pycha
uCyt+ test: alternative to cystoscopy for less-invasive follow-up of patients with low risk of urothelial carcinoma.
Urology 2006;67(5):950-4.
2006: Gerald L Andriole; Michael Marberger; Claus G Roehrborn
Clinical usefulness of serum prostate specific antigen for the detection of prostate cancer is preserved in men receiving the dual 5alpha-reductase inhibitor dutasteride.
The Journal of urology 2006;175(5):1657-62.
2006: Pierre I Karakiewicz; Serge Benayoun; Craig D Zippe; Gerson Lüdecke; Hans Boman; Marta Sanchez-Carbayo; Roberto Casella; Christine Mian; Martin G Friedrich; Sanaa Eissa; Hideyuki Akaza; Hartwig Huland; Hans Hedelin; Raina Rupesh; Naoto Miyanaga; Arthur I Sagalowsky; Michael Marberger; Shahrokh F Shariat
Institutional variability in the accuracy of urinary cytology for predicting recurrence of transitional cell carcinoma of the bladder.
BJU international 2006;97(5):997-1001.
2006: David G Bostwick; Victor E Gould; Junqi Qian; Martin Susani; Michael Marberger
Prostate cancer detected by uPM3: radical prostatectomy findings.
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 2006;19(5):630-3.
2006: Michael Marberger; Claus G Roehrborn; Leonard S Marks; Timothy Wilson; Roger S Rittmaster
Relationship among serum testosterone, sexual function, and response to treatment in men receiving dutasteride for benign prostatic hyperplasia.
The Journal of clinical endocrinology and metabolism 2006;91(4):1323-8.
2006: H Christoph Klingler; Michael Marberger
Incontinence after radical prostatectomy: surgical treatment options.
Current opinion in urology 2006;16(2):60-4.
2006: Christian Seitz; Harun Fajkovic; Matthias Waldert; Enis Tanovic; Mesut Remzi; Gero Kramer; Michael Marberger
Extracorporeal shock wave lithotripsy in the treatment of proximal ureteral stones: Does the presence and degree of hydronephrosis affect success?
European urology 2006;49(2):378-83.
2006: Gero Kramer; Michael Marberger
Could inflammation be a key component in the progression of benign prostatic hyperplasia?
Current opinion in urology 2006;16(1):25-9.
2006: Jakob E Lackner; Georg Schatzl; Sabine Horvath; Christian Kratzik; Michael Marberger
Value of counting white blood cells (WBC) in semen samples to predict the presence of bacteria.
European urology 2006;49(1):148-52; discussion 152-3.
2005: Tomonori Habuchi; Michael Marberger; Michael J Droller; George P Hemstreet; H Barton Grossman; Jack A Schalken; Bernd J Schmitz-Dräger; William M Murphy; Aldo V Bono; Peter Goebell; Robert H Getzenberg; Stefan H Hautmann; Edward Messing; Yves Fradet; Vinata B Lokeshwar
Prognostic markers for bladder cancer: International Consensus Panel on bladder tumor markers.
Urology 2005;66(6 Suppl 1):64-74.
2005: Vinata B Lokeshwar; Tomonori Habuchi; H Barton Grossman; William M Murphy; Stefan H Hautmann; George P Hemstreet; Aldo V Bono; Robert H Getzenberg; Peter Goebell; Bernd J Schmitz-Dräger; Jack A Schalken; Yves Fradet; Michael Marberger; Edward Messing; Michael J Droller
Bladder tumor markers beyond cytology: International Consensus Panel on bladder tumor markers.
Urology 2005;66(6 Suppl 1):35-63.
2005: Jakob E Lackner; Georg Schatzl; Thomas Waldhör; Katharina Resch; Christian Kratzik; Michael Marberger
Constant decline in sperm concentration in infertile males in an urban population: experience over 18 years.
Fertility and sterility 2005;84(6):1657-61.
2005: Mesut Remzi; Yan Kit Fong; Michael Dobrovits; Theodore Anagnostou; Christian Seitz; Matthias Waldert; Mike Harik; Sibylle Marihart; Michael Marberger; Bob Djavan
The Vienna nomogram: validation of a novel biopsy strategy defining the optimal number of cores based on patient age and total prostate volume.
The Journal of urology 2005;174(4 Pt 1):1256-60; discussion 1260-1; author reply 1261.
2005: Jakob E Lackner; Georg Schatzl; Anke Koller; Peter R Mazal; Thomas Waldhoer; Michael Marberger; Christian Kratzik
Treatment of testicular cancer: influence on pituitary-gonadal axis and sexual function.
Urology 2005;66(2):402-6.
2005: Mesut Remzi; H Christoph Klingler; Martina Tinzl; Yan Kit Fong; Michele Lodde; B Kiss; Michael Marberger
Morbidity of laparoscopic extraperitoneal versus transperitoneal radical prostatectomy verus open retropubic radical prostatectomy.
European urology 2005;48(1):83-9; discussion 89.
2005: Georg Schatzl; Michael Marberger; Mesut Remzi; Petra Grösser; Julia Unterlechner; Gerald Haidinger; Thomas Zidek; Martin Preyer; Michael Micksche; Andrea Gsur
Polymorphism in ARE-I region of prostate-specific antigen gene associated with low serum testosterone level and high-grade prostate cancer.
Urology 2005;65(6):1141-5.
2005: Shahrokh F Shariat; Craig D Zippe; Gerson Lüdecke; Hans Boman; Marta Sanchez-Carbayo; Roberto Casella; Christine Mian; Martin G Friedrich; Sanaa Eissa; Hideyuki Akaza; Ihor S Sawczuk; Vincenzo Serretta; Hartwig Huland; Hans Hedelin; Raina Rupesh; Naoto Miyanaga; Arthur I Sagalowsky; Frank H Wians; Claus G Roehrborn; Yair Lotan; Paul Perrotte; Serge Benayoun; Michael Marberger; Pierre I Karakiewicz
Nomograms including nuclear matrix protein 22 for prediction of disease recurrence and progression in patients with Ta, T1 or CIS transitional cell carcinoma of the bladder.
The Journal of urology 2005;173(5):1518-25.
2005: Michael Marberger; Georg Schatzl; David W Cranston; James E Kennedy
Extracorporeal ablation of renal tumours with high-intensity focused ultrasound.
BJU international 2005;95 Suppl 2():52-5.
2005: W Loidl; Jörg Schmidbauer; Martin Susani; Michael Marberger
Flexible cystoscopy assisted by hexaminolevulinate induced fluorescence: a new approach for bladder cancer detection and surveillance?
European urology 2005;47(3):323-6.
2005: Bob Djavan; Yan Kit Fong; Vincent Ravery; Mesut Remzi; Wolfgang Horninger; Martin Susani; Sören Kreuzer; Laurent Boccon-Gibod; Georg Bartsch; Michael Marberger
Are repeat biopsies required in men with PSA levels < or =4 ng/ml? A Multiinstitutional Prospective European Study.
European urology 2005;47(1):38-44; discussion 44.
2004: Bob Djavan; Yan Kit Fong; Mike Harik; Shirin Milani; Andreas Reissigl; Aziz Chaudry; Theodore Anagnostou; Fariborz Bagheri; Matthias Waldert; Sören Kreuzer; Harun Fajkovic; Michael Marberger
Longitudinal study of men with mild symptoms of bladder outlet obstruction treated with watchful waiting for four years.
Urology 2004;64(6):1144-8.
2004: Bob Djavan; Christopher Chapple; Shirin Milani; Michael Marberger
State of the art on the efficacy and tolerability of alpha1-adrenoceptor antagonists in patients with lower urinary tract symptoms suggestive of benign prostatic hyperplasia.
Urology 2004;64(6):1081-8.
2004: Darracott Vaughan; Michael Marberger
A conversation between Darracott Vaughan and Michael Marberger.
BJU international 2004;94(7):961-2.
2004: Gerald L Andriole; David Bostwick; Otis W Brawley; Leonard G Gomella; Michael Marberger; Donald Tindall; Sharon Breed; Matt Somerville; Roger S Rittmaster
Chemoprevention of prostate cancer in men at high risk: rationale and design of the reduction by dutasteride of prostate cancer events (REDUCE) trial.
The Journal of urology 2004;172(4 Pt 1):1314-7.
2004: Martin Susani; Andrea Haitel; Michael Marberger
Prognostic factors in Bilharzial-related bladder cancer.
Human pathology 2004;35(9):1167-8; author reply 1168.
2004: Martina Tinzl; Michael Marberger; Sabine Horvath; Camille Chypre
DD3PCA3 RNA analysis in urine--a new perspective for detecting prostate cancer.
European urology 2004;46(2):182-6; discussion 187.
2004: Bernhard Planz; Horia Oltean; Thomas Deix; Sandra D Kirley; Qi Fa Wang; W Scott McDougal; Michael Marberger
Effect of keratinocyte growth factor and activin on cell growth in the human prostatic cancer cell line LNCaP.
World journal of urology 2004;22(2):140-4.
2004: Gero Kramer; Georg E Steiner; Christoph Neumayer; M Prinz-Kashani; M Hohenfellner; M Gomha; M Ghoneim; Martin Newman; Michael Marberger
Over-expression of anti-CD75 reactive proteins on distal and collecting renal tubular epithelial cells in calcium-oxalate stone-forming kidneys in Egypt.
BJU international 2004;93(6):822-6.
2004: Michael Marberger; Richard C Harkaway; Jean J M C H de la Rosette
Optimising the medical management of benign prostatic hyperplasia.
European urology 2004;45(4):411-9.
2004: Gero Kramer; Hamdiye Erdal; Helena J M M Mertens; Marius Nap; Julian Mauermann; Georg Steiner; Michael Marberger; Kenneth Bivén; Maria C Shoshan; Stig Linder
Differentiation between cell death modes using measurements of different soluble forms of extracellular cytokeratin 18.
Cancer research 2004;64(5):1751-6.
2004: Gero Kramer; Georg E Steiner; Marion Gröbl; Kristian Hrachowitz; Franz Reithmayr; Ljubomir Paucz; Martin Newman; Stephan Madersbacher; Diego Gruber; Martin Susani; Michael Marberger
Response to sublethal heat treatment of prostatic tumor cells and of prostatic tumor infiltrating T-cells.
The Prostate 2004;58(2):109-20.
2004: Bob Djavan; Alexandre R Zlotta; Claude Schulman; Pierre Teillac; Peter Iversen; Laurent Boccon-Gibod; Georg Bartsch; Michael Marberger
Chemotherapeutic prevention studies of prostate cancer.
The Journal of urology 2004;171(2 Pt 2):S10-3; discussion S13-4.
2004: Bob Djavan; Matthias Waldert; Clemens Ghawidel; Michael Marberger
Benign prostatic hyperplasia progression and its impact on treatment.
Current opinion in urology 2004;14(1):45-50.
2004: Bernhard Planz; Shahin Tabatabaei; Sandra D Kirley; H Thomas Aretz; QiFa Wang; C-W Lin; W Scott McDougal; Michael Marberger
Studies on the differentiation pathway and growth characteristics of epithelial culture cells of the human prostate.
Prostate cancer and prostatic diseases 2004;7(1):73-83.
2004: Erich K. Lang; Raju Thomas; Rodney Davis; L Myers; A Sabel; Richard J Macchia; Brian Gayle; R Watson; T Cho; Frank Richter; Gerhard Lechner; Michael Marberger; T Helbich
Multiphasic helical computerized tomography for the assessment of microscopic hematuria: a prospective study.
The Journal of urology 2004;171(1):237-43.
2004: Jörg Schmidbauer; Fred Witjes; Nikolaus Schmeller; Roland Donat; Martin Susani; Michael Marberger
Improved detection of urothelial carcinoma in situ with hexaminolevulinate fluorescence cystoscopy.
The Journal of urology 2004;171(1):135-8.
2003: Christine Mian; Michele Lodde; Evi Comploj; Giovanni Negri; Eduard Egarter-Vigl; Lukas Lusuardi; Salvatore Palermo; Michael Marberger; Armin Pycha
Liquid-based cytology as a tool for the performance of uCyt+ and Urovysion Multicolour-FISH in the detection of urothelial carcinoma.
Cytopathology : official journal of the British Society for Clinical Cytology 2003;14(6):338-42.
2003: Michael Marberger; J Adolfsson; A Borkowski; J Fitzpatrick; D Kirk; D Prezioso; C Rabaça; E Solsona; Pierre Teillac
The clinical implications of the prostate cancer prevention trial.
BJU international 2003;92(7):667-71.
2003: Catharina Wenzel; Gottfried J Locker; Rupert Bartsch; Ursula Pluschnig; Robert Mader; Dagmar Hussian; Gero Kramer; Michael Marberger; Christian Lintner; Michael Rauchenwald; Christoph C Zielinski; Guenther G Steger
Capecitabine monotherapy and in combination with immunotherapy in the treatment of metastatic renal cell carcinoma.
Anti-cancer drugs 2003;14(10):779-84.
2003: Stephan Madersbacher; Michael Marberger
High-energy shockwaves and extracorporeal high-intensity focused ultrasound.
Journal of endourology / Endourological Society 2003;17(8):667-72.
2003: H Christoph Klingler; Michele Lodde; Armin Pycha; Mesut Remzi; Günter Janetschek; Michael Marberger
Modified laparoscopic nephroureterectomy for treatment of upper urinary tract transitional cell cancer is not associated with an increased risk of tumour recurrence.
European urology 2003;44(4):442-7.
2003: Mesut Remzi; Theodore Anagnostou; Vincent Ravery; Alexandre R Zlotta; Carsten Stephan; Michael Marberger; Bob Djavan
An artificial neural network to predict the outcome of repeat prostate biopsies.
Urology 2003;62(3):456-60.
2003: H Christoph Klingler; Mesut Remzi; Günter Janetschek; Christian Kratzik; Michael Marberger
Comparison of open versus laparoscopic pyeloplasty techniques in treatment of uretero-pelvic junction obstruction.
European urology 2003;44(3):340-5.
2003: Alexander Kober; Michael Dobrovits; Bob Djavan; Michael Marberger; Renate Barker; Petra Bertalanffy; Thomas Scheck; Burkhard Gustorff; Klaus Hoerauf
Local active warming: an effective treatment for pain, anxiety and nausea caused by renal colic.
The Journal of urology 2003;170(3):741-4.
2003: Georg E Steiner; Ursula Stix; Alessandra Handisurya; Martin Willheim; Andrea Haitel; Franz Reithmayr; Doris Paikl; Rupert C Ecker; Kristian Hrachowitz; Gero Kramer; Chung Lee; Michael Marberger
Cytokine expression pattern in benign prostatic hyperplasia infiltrating T cells and impact of lymphocytic infiltration on cytokine mRNA profile in prostatic tissue.
Laboratory investigation; a journal of technical methods and pathology 2003;83(8):1131-46.
2003: Georg E Steiner; Martin E Newman; Doris Paikl; Ursula Stix; Nima Memaran-Dagda; Chung Lee; Michael Marberger
Expression and function of pro-inflammatory interleukin IL-17 and IL-17 receptor in normal, benign hyperplastic, and malignant prostate.
The Prostate 2003;56(3):171-82.
2003: Irene Sulzbacher; Peter Birner; Margit Träxler; Michael Marberger; Andrea Haitel
Expression of platelet-derived growth factor-alpha alpha receptor is associated with tumor progression in clear cell renal cell carcinoma.
American journal of clinical pathology 2003;120(1):107-12.
2003: Bob Djavan; Mesut Remzi; Michael Marberger
When to biopsy and when to stop biopsying.
The Urologic clinics of North America 2003;30(2):253-62, viii.
2003: H Christoph Klingler; Mesut Remzi; Günter Janetschek; Michael Marberger
Benefits of laparoscopic renal surgery are more pronounced in patients with a high body mass index.
European urology 2003;43(5):522-7.
2003: Alexandre R Zlotta; Mesut Remzi; Peter B Snow; Claude C Schulman; Michael Marberger; Bob Djavan
An artificial neural network for prostate cancer staging when serum prostate specific antigen is 10 ng./ml. or less.
The Journal of urology 2003;169(5):1724-8.
2003: Gero Kramer; Georg E Steiner; M Prinz-Kashani; B Bursa; Michael Marberger
Cell-surface matrix proteins and sialic acids in cell-crystal adhesion; the effect of crystal binding on the viability of human CAKI-1 renal epithelial cells.
BJU international 2003;91(6):554-9.
2003: Georg Schatzl; Stephan Madersbacher; Andrea Haitel; Andrea Gsur; Martin Preyer; Gerald Haidinger; Christa Gassner; Michaela Ochsner; Michael Marberger
Associations of serum testosterone with microvessel density, androgen receptor density and androgen receptor gene polymorphism in prostate cancer.
The Journal of urology 2003;169(4):1312-5.
2003: Georg Schatzl; Stephan Madersbacher; Christian Temml; Karin Krenn-Schinkel; Andreas Nader; Gabor Sregi; Alexander Lapin; Martin Hermann; Peter Berger; Michael Marberger
Serum androgen levels in men: impact of health status and age.
Urology 2003;61(3):629-33.
2003: Erich K. Lang; Richard J Macchia; Raju Thomas; Richard A Watson; Michael Marberger; Gerhard Lechner; Brian Gayle; Frank Richter
Improved detection of renal pathologic features on multiphasic helical CT compared with IVU in patients presenting with microscopic hematuria.
Urology 2003;61(3):528-32.
2003: Gero Kramer; Georg E Steiner; P Sokol; R Mallone; Gabriele Amann; Michael Marberger
Loss of CD38 correlates with simultaneous up-regulation of human leukocyte antigen-DR in benign prostatic glands, but not in fetal or androgen-ablated glands, and is strongly related to gland atrophy.
BJU international 2003;91(4):409-16.
2003: Michele Lodde; Christine Mian; Giovanni Negri; Lukas Berner; Nicola Maffei; Lukas Lusuardi; Salvatore Palermo; Michael Marberger; Clemens Brssner; Armin Pycha
Role of uCyt+ in the detection and surveillance of urothelial carcinoma.
Urology 2003;61(1):243-7.
2003: Mesut Remzi; Bob Djavan; Robert Wammack; M Momeni; Christian Seitz; Beate Erne; Michael Dobrovits; S Alavi; Michael Marberger
Can total and transition zone volume of the prostate determine whether to perform a repeat biopsy?
Urology 2003;61(1):161-6.
2003: Bob Djavan; C Seitz; Michael Marberger
Heat versus drugs in the treatment of benign prostatic hyperplasia.
BJU international 2003;91(2):131-7.
2003: H Christoph Klingler; Gero Kramer; Michele Lodde; K Dorfinger; Josef Hofbauer; Michael Marberger
Stone treatment and coagulopathy.
European urology 2003;43(1):75-9.
2002: Bob Djavan; Mesut Remzi; Beate Erne; Michael Marberger
The pathophysiology of benign prostatic hyperplasia.
Drugs of today (Barcelona, Spain : 1998) 2002;38(12):867-76.
2002: Stephan Madersbacher; Georg Schatzl; Christian Bieglmayer; Werner J Reiter; Christa Gassner; Peter Berger; Thomas Zidek; Michael Marberger
Impact of radical prostatectomy and TURP on the hypothalamic-pituitary-gonadal hormone axis.
Urology 2002;60(5):869-74.
2002: Bob Djavan; Mesut Remzi; Alexandre R Zlotta; Vincent Ravery; Peter Hammerer; Andreas Reissigl; Piotr Dobronski; Amir Kaisary; Michael Marberger
Complexed prostate-specific antigen, complexed prostate-specific antigen density of total and transition zone, complexed/total prostate-specific antigen ratio, free-to-total prostate-specific antigen ratio, density of total and transition zone prostate-specific antigen: results of the prospective multicenter European trial.
Urology 2002;60(4 Suppl 1):4-9.
2002: Andrea Gsur; Martin Preyer; Gerald Haidinger; Thomas Zidek; Stephan Madersbacher; Georg Schatzl; Michael Marberger; Christian Vutuc; Michael Micksche
Polymorphic CAG repeats in the androgen receptor gene, prostate-specific antigen polymorphism and prostate cancer risk.
Carcinogenesis 2002;23(10):1647-51.
2002: Bob Djavan; Mesut Remzi; Claude C Schulman; Michael Marberger; Alexandre R Zlotta
Repeat prostate biopsy: who, how and when?. a review.
European urology 2002;42(2):93-103.
2002: Georg Schatzl; Stephan Madersbacher; Andrea Gsur; Martin Preyer; Gerald Haidinger; Andrea Haitel; Christian Vutuc; Michael Micksche; Michael Marberger
Association of polymorphisms within androgen receptor, 5alpha-reductase, and PSA genes with prostate volume, clinical parameters, and endocrine status in elderly men.
The Prostate 2002;52(2):130-8.
2002: Robert Wammack; Mesut Remzi; Christian Seitz; Bob Djavan; Michael Marberger
Efficacy of oral doxepin and piroxicam treatment for interstitial cystitis.
European urology 2002;41(6):596-600; discussion 601.
2002: Gero Kramer; Georg E Steiner; Alessandra Handisurya; Ursula Stix; Andrea Haitel; Birgit Knerer; Alois Gessl; Chung Lee; Michael Marberger
Increased expression of lymphocyte-derived cytokines in benign hyperplastic prostate tissue, identification of the producing cell types, and effect of differentially expressed cytokines on stromal cell proliferation.
The Prostate 2002;52(1):43-58.
2002: Andrea Gsur; Martin Preyer; Gerald Haidinger; Georg Schatzl; Stephan Madersbacher; Michael Marberger; Christian Vutuc; Michael Micksche
A polymorphism in the UDP-Glucuronosyltransferase 2B15 gene (D85Y) is not associated with prostate cancer risk.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2002;11(5):497-8.
2002: Werner J Reiter; Sandra Tomek; Christoph C Zielinski; Michael Marberger
Effect of carboplatin on the functional integrity of the human sperm membrane in vitro.
Journal of andrology 2002;23(3):338-40.
2002: Andrea Gsur; Stephan Madersbacher; Gerald Haidinger; Georg Schatzl; Michael Marberger; Christian Vutuc; Michael Micksche
Vitamin D receptor gene polymorphism and prostate cancer risk.
The Prostate 2002;51(1):30-4.
2002: Maria Flamm; Thomas Brodowicz; Andrea Haitel; Martin Susani; Sandra Tomek; Wolfgang J Köstler; Armin Pycha; Christian Kratzik; Michael Marberger; Christoph C Zielinski
Correlation of clinical outcome with p53 and p21 status in patients with advanced transitional-cell carcinoma treated with paclitaxel and carboplatin.
Anticancer research 2002;22(2B):1295-300.
2002: H Christoph Klingler; Gero Kramer; Michele Lodde; Michael Marberger
Urolithiasis in allograft kidneys.
Urology 2002;59(3):344-8.
2002: Bob Djavan; Mesut Remzi; Alexandre R Zlotta; Christian Seitz; Peter Snow; Michael Marberger
Novel artificial neural network for early detection of prostate cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2002;20(4):921-9.
2002: Erich K. Lang; Richard J Macchia; Raju Thomas; Gilberto Ruiz-Deya; Richard A Watson; Frank Richter; Robert Irwin R; Michael Marberger; Jack H Mydlo; Gerhard Lechner; Kyunghee C Cho; Brian Gayle
Computerized tomography tailored for the assessment of microscopic hematuria.
The Journal of urology 2002;167(2 Pt 1):547-54.
2002: Georg E Steiner; Bob Djavan; Gero Kramer; Alessandra Handisurya; Martin Newman; Chung Lee; Michael Marberger
The picture of the prostatic lymphokine network is becoming increasingly complex.
Reviews in urology 2002;4(4):171-7.
2002: Catharina Wenzel; Gottfried J Locker; Manuela Schmidinger; Robert Mader; Gero Kramer; Michael Marberger; Michael Rauchenwald; Christoph C Zielinski; Guenther G Steger
Capecitabine in the treatment of metastatic renal cell carcinoma failing immunotherapy.
American journal of kidney diseases : the official journal of the National Kidney Foundation 2002;39(1):48-54.
2002: Christian Seitz; Bob Djavan; Michael Marberger
Morphological and biological predictors for treatment outcome of transurethral microwave thermotherapy.
Current opinion in urology 2002;12(1):25-32.
2001: Alessandra Handisurya; Georg E Steiner; Ursula Stix; Rupert C Ecker; S Pfaffeneder-Mantai; D Langer; Gero Kramer; N Memaran-Dadgar; Michael Marberger
Differential expression of interleukin-15, a pro-inflammatory cytokine and T-cell growth factor, and its receptor in human prostate.
The Prostate 2001;49(4):251-62.
2001: Robert Wammack; Bob Djavan; Mesut Remzi; Martin Susani; Michael Marberger
Morbidity of transrectal ultrasound-guided prostate needle biopsy in patients receiving immunosuppression.
Urology 2001;58(6):1004-7.
2001: Bob Djavan; Vincent Ravery; Alexandre R Zlotta; Piotr Dobronski; Michael Dobrovits; Mitra Fakhari; Christian Seitz; Martin Susani; A Borkowski; Laurent Boccon-Gibod; Claude C Schulman; Michael Marberger
Prospective evaluation of prostate cancer detected on biopsies 1, 2, 3 and 4: when should we stop?
The Journal of urology 2001;166(5):1679-83.
2001: Gero Kramer; Georg E Steiner; S Paiha; Alessandra Handisurya; Bob Djavan; R Mallone; Michael Marberger
Human accessory cells activate fresh, normal, tumor-distant T lymphocytes but not tumor-infiltrating T lymphocytes to lyse autologous tumor cells in a primary cytotoxic T lymphocyte assay in renal cell carcinoma.
European urology 2001;40(4):427-33.
2001: Andrea Haitel; Helene G Wiener; B Neudert; Michael Marberger; Martin Susani
Expression of the cell cycle proteins p21, p27, and pRb in clear cell renal cell carcinoma and their prognostic significance.
Urology 2001;58(3):477-81.
2001: Michele Lodde; Christine Mian; Helene G Wiener; Andrea Haitel; Armin Pycha; Michael Marberger
Detection of upper urinary tract transitional cell carcinoma with ImmunoCyt: a preliminary report.
Urology 2001;58(3):362-6.
2001: Bob Djavan; Matthias Waldert; Alexandre R Zlotta; Piotr Dobronski; Christian Seitz; Mesut Remzi; A Borkowski; Claude Schulman; Michael Marberger
Safety and morbidity of first and repeat transrectal ultrasound guided prostate needle biopsies: results of a prospective European prostate cancer detection study.
The Journal of urology 2001;166(3):856-60.
2001: Werner J Reiter; Georg Schatzl; Isabel Märk; Andrea Zeiner; Armin Pycha; Michael Marberger
Dehydroepiandrosterone in the treatment of erectile dysfunction in patients with different organic etiologies.
Urological research 2001;29(4):278-81.
2001: Bob Djavan; Matthias Waldert; Christian Seitz; Michael Marberger
Insulin-like growth factors and prostate cancer.
World journal of urology 2001;19(4):225-33.
2001: Bernhard Planz; QiFa Wang; Sandra D Kirley; Michael Marberger; W Scott McDougal
Regulation of keratinocyte growth factor receptor and androgen receptor in epithelial cells of the human prostate.
The Journal of urology 2001;166(2):678-83.
2001: Gero Kramer; Georg E Steiner; P Sokol; Alessandra Handisurya; H Christoph Klingler; U Maier; M Földy; Michael Marberger
Local intratumoral tumor necrosis factor-alpha and systemic IFN-alpha 2b in patients with locally advanced prostate cancer.
Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research 2001;21(7):475-84.
2001: Andrea Gsur; Gerald Haidinger; S Hinteregger; G Bernhofer; Georg Schatzl; Stephan Madersbacher; Michael Marberger; Christian Vutuc; Michael Micksche
Polymorphisms of glutathione-S-transferase genes (GSTP1, GSTM1 and GSTT1) and prostate-cancer risk.
International journal of cancer. Journal international du cancer 2001;95(3):152-5.
2001: Andrea Haitel; B Posch; Mahmoud El-Baz; A A Mokhtar; Martin Susani; MA Ghoneim; Michael Marberger
Bilharzial related, organ confined, muscle invasive bladder cancer: prognostic value of apoptosis markers, proliferation markers, p53, E-cadherin, epidermal growth factor receptor and c-erbB-2.
The Journal of urology 2001;165(5):1481-7.
2001: Bob Djavan; Peter R Mazal; Alexandre R Zlotta; Robert Wammack; Vincent Ravery; Mesut Remzi; Martin Susani; A Borkowski; S Hruby; Laurent Boccon-Gibod; Claude C Schulman; Michael Marberger
Pathological features of prostate cancer detected on initial and repeat prostate biopsy: results of the prospective European Prostate Cancer Detection study.
The Prostate 2001;47(2):111-7.
2001: Georg Schatzl; Stephan Madersbacher; T Thurridl; J Waldmüller; Gero Kramer; Andrea Haitel; Michael Marberger
High-grade prostate cancer is associated with low serum testosterone levels.
The Prostate 2001;47(1):52-8.
2001: Georg Schatzl; Andrea Gsur; G Bernhofer; Gerald Haidinger; S Hinteregger; Christian Vutuc; Andrea Haitel; Michael Micksche; Michael Marberger; Stephan Madersbacher
Association of vitamin D receptor and 17 hydroxylase gene polymorphisms with benign prostatic hyperplasia and benign prostatic enlargement.
Urology 2001;57(3):567-72.
2001: Bernhard Planz; C Synek; Thomas Deix; Alfred Böcking; Michael Marberger
Diagnosis of bladder cancer with urinary cytology, immunocytology and DNA-image-cytometry.
Analytical cellular pathology : the journal of the European Society for Analytical Cellular Pathology 2001;22(3):103-9.
2001: Bob Djavan; Christian Seitz; Claus G Roehrborn; Mesut Remzi; Mitra Fakhari; Matthias Waldert; A Basharkhah; Bernhard Planz; Mike Harik; Michael Marberger
Targeted transurethral microwave thermotherapy versus alpha-blockade in benign prostatic hyperplasia: outcomes at 18 months.
Urology 2001;57(1):66-70.
2001: Bob Djavan; Michael Marberger
Minimally invasive procedures as an alternative to medical management for lower urinary tract symptoms of benign prostatic hyperplasia.
Current opinion in urology 2001;11(1):1-7.
2001: Werner J Reiter; Thomas Brodowicz; S Alavi; Christoph C Zielinski; W Kozak; Ulrich Maier; G Nöst; H Lipsky; Michael Marberger; Christian Kratzik
Twelve-year experience with two courses of adjuvant single-agent carboplatin therapy for clinical stage I seminoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2001;19(1):101-4.
2000: Bob Djavan; Robert Wammack; K Ghawidel; S Alavi; C Hasenzagel; Piotr Dobronski; A Stoklosa; T Jakubcky; A Borkowski; Michael Marberger
Microwave thermotherapy in patients with chronic urinary retention.
Techniques in urology 2000;6(4):278-81.
2000: B Bursa; Robert Wammack; Bob Djavan; Bernhard Planz; Matthias Waldert; T Dobronski; T Stoklosa; T Borkowski; T Jakubcky; Michael Marberger
Outcome predictors of high-energy transurethral microwave thermotherapy.
Techniques in urology 2000;6(4):262-6.
2000: Michael Marberger; Jens Thorup Andersen; J Curtis Nickel; MP Malice; M Gabriel; Frances Pappas; Alan G Meehan; Elizabeth Stoner; Joanne Waldstreicher
Prostate volume and serum prostate-specific antigen as predictors of acute urinary retention. Combined experience from three large multinational placebo-controlled trials.
European urology 2000;38(5):563-8.
2000: Bernhard Planz; C Synek; J Robben; Alfred Böcking; Michael Marberger
Diagnostic accuracy of DNA image cytometry and urinary cytology with cells from voided urine in the detection of bladder cancer.
Urology 2000;56(5):782-6.
2000: H Christoph Klingler; Armin Pycha; Jörg Schmidbauer; Michael Marberger
Use of peripheral neuromodulation of the S3 region for treatment of detrusor overactivity: a urodynamic-based study.
Urology 2000;56(5):766-71.
2000: Bob Djavan; Michael Marberger
Transurethral microwave thermotherapy: an alternative to medical management in patients with benign prostatic hyperplasia?
Journal of endourology / Endourological Society 2000;14(8):661-9.
2000: Mesut Remzi; R Buchsteiner; Bob Djavan; A Hittmair; Christian Seitz; C Klingler; Michael Marberger
Unilateral nondisseminated actinomycosis of the hydrocele wall: a case report of actinomycosis in the urogenital tract.
Techniques in urology 2000;6(3):228-30.
2000: Christine Mian; Michele Lodde; Andrea Haitel; Eduard Egarter-Vigl; Michael Marberger; Armin Pycha
Comparison of two qualitative assays, the UBC rapid test and the BTA stat test, in the diagnosis of urothelial cell carcinoma of the bladder.
Urology 2000;56(2):228-31.
2000: Andrea Gsur; G Bernhofer; S Hinteregger; Gerald Haidinger; Georg Schatzl; Stephan Madersbacher; Michael Marberger; Christian Vutuc; Michael Micksche
A polymorphism in the CYP17 gene is associated with prostate cancer risk.
International journal of cancer. Journal international du cancer 2000;87(3):434-7.
2000: Bob Djavan; Alexandre R Zlotta; Samuel Ekane; Mesut Remzi; Gero Kramer; Thierry Roumeguère; M Etemad; R Wolfram; Claude C Schulman; Michael Marberger
Is one set of sextant biopsies enough to rule out prostate Cancer? Influence of transition and total prostate volumes on prostate cancer yield.
European urology 2000;38(2):218-24.
2000: D Hahn; R Simak; Georg E Steiner; Alessandra Handisurya; Martin Susani; Michael Marberger
Expression of the VEGF-receptor Flt-1 in benign, premalignant and malignant prostate tissues.
The Journal of urology 2000;164(2):506-10.
2000: Günter Janetschek; Michael Marberger
Laparoscopic surgery in urology.
Current opinion in urology 2000;10(4):351-7.
2000: Georg Schatzl; Stephan Madersbacher; Bob Djavan; Thomas Lang; Michael Marberger
Two-year results of transurethral resection of the prostate versus four 'less invasive' treatment options.
European urology 2000;37(6):695-701.
2000: Stephan Madersbacher; Georg Schatzl; Bob Djavan; T Stulnig; Michael Marberger
Long-term outcome of transrectal high- intensity focused ultrasound therapy for benign prostatic hyperplasia.
European urology 2000;37(6):687-94.
2000: Werner J Reiter; Armin Pycha; Georg Schatzl; H Christoph Klingler; Isabel Märk; Alexandra Auterith; Michael Marberger
Serum dehydroepiandrosterone sulfate concentrations in men with erectile dysfunction.
Urology 2000;55(5):755-8.
2000: Georg E Steiner; Rupert C Ecker; Gero Kramer; F Stockenhuber; Michael Marberger
Automated data acquisition by confocal laser scanning microscopy and image analysis of triple stained immunofluorescent leukocytes in tissue.
Journal of immunological methods 2000;237(1-2):39-50.
2000: Bob Djavan; Alexandre R Zlotta; Mesut Remzi; K Ghawidel; A Basharkhah; Claude C Schulman; Michael Marberger
Optimal predictors of prostate cancer on repeat prostate biopsy: a prospective study of 1,051 men.
The Journal of urology 2000;163(4):1144-8; discussion 1148-9.
2000: Christine Mian; Michele Lodde; Andrea Haitel; E E Vigl; Michael Marberger; Armin Pycha
Comparison of the monoclonal UBC-ELISA test and the NMP22 ELISA test for the detection of urothelial cell carcinoma of the bladder.
Urology 2000;55(2):223-6.
2000: Bob Djavan; B Bursa; A Basharkhah; Christian Seitz; Mesut Remzi; K Ghawidel; S Hruby; Michael Marberger
Pretreatment prostate-specific antigen as an outcome predictor of targeted transurethral microwave thermotherapy.
Urology 2000;55(1):51-7.
2000: Bob Djavan; Alan W Partin; M F Hoey; Claus G Roehrborn; C M Dixon; Michael Marberger
Transurethral radiofrequency therapy for benign prostatic hyperplasia using a novel saline-liquid conductor: the virtual electrode.
Urology 2000;55(1):13-6.
2000: Stephan Madersbacher; Florian Thalhammer; Michael Marberger
Pathogenesis and management of recurrent urinary tract infection in women.
Current opinion in urology 2000;10(1):29-33.
1999: Bob Djavan; Alexandre R Zlotta; Mesut Remzi; K Ghawidel; B Bursa; S Hruby; R Wolfram; Claude C Schulman; Michael Marberger
Total and transition zone prostate volume and age: how do they affect the utility of PSA-based diagnostic parameters for early prostate cancer detection?
Urology 1999;54(5):846-52.
1999: Bob Djavan; B Bursa; Christian Seitz; G Soeregi; Mesut Remzi; A Basharkhah; R Wolfram; Michael Marberger
Insulin-like growth factor 1 (IGF-1), IGF-1 density, and IGF-1/PSA ratio for prostate cancer detection.
Urology 1999;54(4):603-6.
1999: Alexandre R Zlotta; Bob Djavan; M Damoun; Thierry Roumeguere; Michel Petein; K Entezari; Michael Marberger; Claude C Schulman
The importance of measuring the prostatic transition zone: an anatomical and radiological study.
BJU international 1999;84(6):661-6.
1999: H Christoph Klingler; Christian Kratzik; Armin Pycha; Michael Marberger
Value of power Doppler sonography in the investigation of erectile dysfunction.
European urology 1999;36(4):320-6.
1999: Bob Djavan; Martin Susani; B Bursa; A Basharkhah; R Simak; Michael Marberger
Predictability and significance of multifocal prostate cancer in the radical prostatectomy specimen.
Techniques in urology 1999;5(3):139-42.
1999: Bob Djavan; Alexandre R Zlotta; Christian Kratzik; Mesut Remzi; Christian Seitz; Claude C Schulman; Michael Marberger
PSA, PSA density, PSA density of transition zone, free/total PSA ratio, and PSA velocity for early detection of prostate cancer in men with serum PSA 2.5 to 4.0 ng/mL.
Urology 1999;54(3):517-22.
1999: Georg Schatzl; Stephan Madersbacher; Josef Hofbauer; Armin Pycha; Werner J Reiter; G Svolba; Michael Marberger
The impact of urinary extravasation after radical retropubic prostatectomy on urinary incontinence and anastomotic strictures.
European urology 1999;36(3):187-90.
1999: Bob Djavan; Victor Lin; C Seitz; Gero Kramer; P Kaplan; JC Richier; Michael Marberger; John D McConnell
Elastin gene expression in benign prostatic hyperplasia.
The Prostate 1999;40(4):242-7.
1999: Bob Djavan; K Ghawidel; A Basharkhah; S Hruby; B Bursa; Michael Marberger
Temporary intraurethral prostatic bridge-catheter compared with neoadjuvant and adjuvant alpha-blockade to improve early results of high-energy transurethral microwave thermotherapy.
Urology 1999;54(1):73-80.
1999: Bob Djavan; Christian Seitz; K Ghawidel; A Basharkhah; B Bursa; S Hruby; Michael Marberger
High-energy transurethral microwave thermotherapy in patients with acute urinary retention due to benign prostatic hyperplasia.
Urology 1999;54(1):18-22.
1999: Bob Djavan; Mesut Remzi; Alexandre R Zlotta; Christian Seitz; R Wolfram; S Hruby; B Bursa; Claude C Schulman; Michael Marberger
Combination and multivariate analysis of PSA-based parameters for prostate cancer prediction.
Techniques in urology 1999;5(2):71-6.
1999: Bob Djavan; S Shariat; K Ghawidel; K Güven-Marberger; Mesut Remzi; J Kovarik; W H Hoerl; Michael Marberger
Impact of chronic dialysis on serum PSA, free PSA, and free/total PSA ratio: is prostate cancer detection compromised in patients receiving long-term dialysis?
Urology 1999;53(6):1169-74.
1999: Armin Pycha; Christine Mian; B Posch; Andrea Haitel; A A Mokhtar; Mahmoud El-Baz; MA Ghoneim; Michael Marberger
Numerical chromosomal aberrations in muscle invasive squamous cell and transitional cell cancer of the urinary bladder: an alternative to classic prognostic indicators?
Urology 1999;53(5):1005-10.
1999: Christine Mian; Armin Pycha; Helene G Wiener; Andrea Haitel; Michele Lodde; Michael Marberger
Immunocyt: a new tool for detecting transitional cell cancer of the urinary tract.
The Journal of urology 1999;161(5):1486-9.
1999: Werner J Reiter; H Schön-Pernerstorfer; K Dorfinger; Josef Hofbauer; Michael Marberger
Frequency of urolithiasis in individuals seropositive for human immunodeficiency virus treated with indinavir is higher than previously assumed.
The Journal of urology 1999;161(4):1082-4.
1999: Bob Djavan; Stephan Madersbacher; H Christoph Klingler; K Ghawidel; A Basharkhah; S Hruby; Christian Seitz; Michael Marberger
Outcome analysis of minimally invasive treatments for benign prostatic hyperplasia.
Techniques in urology 1999;5(1):12-20.
1999: Werner J Reiter; Armin Pycha; Georg Schatzl; A Pokorny; Doris M Gruber; Johannes C Huber; Michael Marberger
Dehydroepiandrosterone in the treatment of erectile dysfunction: a prospective, double-blind, randomized, placebo-controlled study.
Urology 1999;53(3):590-4; discussion 594-5.
1999: Armin Pycha; M Grbovic; B Posch; B Schnack; Andrea Haitel; Gertraud Heinz-Peer; Christoph C Zielinski; Michael Marberger
Paclitaxel and carboplatin in patients with metastatic transitional cell cancer of the urinary tract.
Urology 1999;53(3):510-5.
1999: Stephan Madersbacher; Michael Marberger
Is transurethral resection of the prostate still justified?
BJU international 1999;83(3):227-37.
1999: Bob Djavan; S Shariat; Mitra Fakhari; K Ghawidel; Christian Seitz; Alan W Partin; Claus G Roehrborn; Michael Marberger
Neoadjuvant and adjuvant alpha-blockade improves early results of high-energy transurethral microwave thermotherapy for lower urinary tract symptoms of benign prostatic hyperplasia: a randomized, prospective clinical trial.
Urology 1999;53(2):251-9.
1999: Bob Djavan; Michael Marberger
A meta-analysis on the efficacy and tolerability of alpha1-adrenoceptor antagonists in patients with lower urinary tract symptoms suggestive of benign prostatic obstruction.
European urology 1999;36(1):1-13.
1999: Stephan Madersbacher; Armin Pycha; Christoph Klingler; Georg Schatzl; Michael Marberger
The International Prostate Symptom score in both sexes: a urodynamics-based comparison.
Neurourology and urodynamics 1999;18(3):173-82.
1999: Stephan Madersbacher; Armin Pycha; Christoph Klingler; Christine Mian; Bob Djavan; T Stulnig; Michael Marberger
Interrelationships of bladder compliance with age, detrusor instability, and obstruction in elderly men with lower urinary tract symptoms.
Neurourology and urodynamics 1999;18(1):3-15.
1999: Bob Djavan; Mitra Fakhari; S Shariat; K Ghawidel; Michael Marberger
A novel intraurethral prostatic bridge catheter for prevention of temporary prostatic obstruction following high energy transurethral microwave thermotherapy in patients with benign prostatic hyperplasia.
The Journal of urology 1999;161(1):144-51.
1999: Bob Djavan; Claus G Roehrborn; S Shariat; K Ghawidel; Michael Marberger
Prospective randomized comparison of high energy transurethral microwave thermotherapy versus alpha-blocker treatment of patients with benign prostatic hyperplasia.
The Journal of urology 1999;161(1):139-43.
1999: Armin Pycha; Christine Mian; Josef Hofbauer; Clemens Brössner; Andrea Haitel; Helene G Wiener; Michael Marberger
Multifocality of transitional cell carcinoma results from genetic instability of entire transitional epithelium.
Urology 1999;53(1):92-7.
1998: Bob Djavan; Mitra Fakhari; Claus G Roehrborn; Michael Marberger
Metabolic consequences of urinary diversion with intestinal segments.
Techniques in urology 1998;4(4):177-81.
1998: Bob Djavan; T R Larson; M L Blute; Michael Marberger
Transurethral microwave thermotherapy: what role should it play versus medical management in the treatment of benign prostatic hyperplasia?
Urology 1998;52(6):935-47.
1998: Alexandre R Zlotta; Bob Djavan; Michel Petein; M Susani; Michael Marberger; Claude C Schulman
Prostate specific antigen density of the transition zone for predicting pathological stage of localized prostate cancer in patients with serum prostate specific antigen less than 10 ng./ml.
The Journal of urology 1998;160(6 Pt 1):2089-95.
1998: Armin Pycha; Christine Mian; Werner J Reiter; Clemens Brössner; Andrea Haitel; Helene G Wiener; Ulrich Maier; Michael Marberger
Nephrogenic adenoma in renal transplant recipients: a truly benign lesion?
Urology 1998;52(5):756-61.
1998: Stephan Madersbacher; M Gröbl; Gero Kramer; S Dirnhofer; Georg E Steiner; Michael Marberger
Regulation of heat shock protein 27 expression of prostatic cells in response to heat treatment.
The Prostate 1998;37(3):174-81.
1998: Bob Djavan; Victor Lin; E P Kaplan; JC Richier; S Shariat; Michael Marberger; John D McConnell
Decreased elastin gene expression in noncompliant human bladder tissue: a competitive reverse transcriptase-polymerase chain reaction analysis.
The Journal of urology 1998;160(5):1658-62.
1998: M Kashani; G Steiner; Andrea Haitel; Katharina Schaufler; Theresia Thalhammer; Gabriele Amann; Gero Kramer; Michael Marberger; A Schöller
Expression of the aryl hydrocarbon receptor (AhR) and the aryl hydrocarbon receptor nuclear translocator (ARNT) in fetal, benign hyperplastic, and malignant prostate.
The Prostate 1998;37(2):98-108.
1998: Bob Djavan; S Shariat; B Schäfer; Michael Marberger
Tolerability of high energy transurethral microwave thermotherapy with topical urethral anesthesia: results of a prospective, randomized, single-blinded clinical trial.
The Journal of urology 1998;160(3 Pt 1):772-6.
1998: Armin Pycha; Christine Mian; B Posch; Andrea Haitel; Mahmoud El-Baz; MA Ghoneim; Michael Marberger
Numerical aberrations of chromosomes 7, 9 and 17 in squamous cell and transitional cell cancer of the bladder: a comparative study performed by fluorescence in situ hybridization.
The Journal of urology 1998;160(3 Pt 1):737-40.
1998: Christoph C Zielinski; B Schnack; M Grbovic; Thomas Brodowicz; Christoph Wiltschke; G Steger; H Pflüger; Michael Marberger
Paclitaxel and carboplatin in patients with metastatic urothelial cancer: results of a phase II trial.
British journal of cancer 1998;78(3):370-4.
1998: Bob Djavan; Alexandre R Zlotta; G Byttebier; S Shariat; M Omar; Claude C Schulman; Michael Marberger
Prostate specific antigen density of the transition zone for early detection of prostate cancer.
The Journal of urology 1998;160(2):411-8; discussion 418-9.
1998: Werner J Reiter; Christian Kratzik; Thomas Brodowicz; Andrea Haitel; A Pokorny; Christoph C Zielinski; Michael Marberger
Sperm analysis and serum follicle-stimulating hormone levels before and after adjuvant single-agent carboplatin therapy for clinical stage I seminoma.
Urology 1998;52(1):117-9.
1998: Bob Djavan; Martin Susani; S Shariat; Alexandre R Zlotta; DE Silverman; Claude C Schulman; Michael Marberger
Transperineal radiofrequency interstitial tumor ablation (RITA) of the prostate.
Techniques in urology 1998;4(2):103-9.
1998: Helene G Wiener; Christine Mian; Andrea Haitel; Armin Pycha; Georg Schatzl; Michael Marberger
Can urine bound diagnostic tests replace cystoscopy in the management of bladder cancer?
The Journal of urology 1998;159(6):1876-80.
1998: Michael Marberger
Long-term effects of finasteride in patients with benign prostatic hyperplasia: a double-blind, placebo-controlled, multicenter study. PROWESS Study Group.
Urology 1998;51(5):677-86.
1998: Stephan Madersbacher; Armin Pycha; Georg Schatzl; Christine Mian; Christoph Klingler; Michael Marberger
The aging lower urinary tract: a comparative urodynamic study of men and women.
Urology 1998;51(2):206-12.
1998: Alexandre R Zlotta; Bob Djavan; C Matos; Jean-Christophe Noel; MO Peny; DE Silverman; Michael Marberger; Claude C Schulman
Percutaneous transperineal radiofrequency ablation of prostate tumour: safety, feasibility and pathological effects on human prostate cancer.
British journal of urology 1998;81(2):265-75.
1998: Stephan Madersbacher; Bob Djavan; Michael Marberger
Minimally invasive treatment for benign prostatic hyperplasia.
Current opinion in urology 1998;8(1):17-26.
1998: Armin Pycha; Christoph Klingler; Andrea Haitel; Gertraud Heinz-Peer; Michael Marberger
Implantable microballoons: an attractive alternative in the management of intrinsic sphincter deficiency.
European urology 1998;33(5):469-75.
1998: A Etele-Hainz; E Artens; Michael Marberger
Therapy concept in enuretic children.
European urology 1998;33 Suppl 3():49-52.
1998: Bob Djavan; K Kadesky; B Klopukh; Michael Marberger; Claus G Roehrborn
Gleason scores from prostate biopsies obtained with 18-gauge biopsy needles poorly predict Gleason scores of radical prostatectomy specimens.
European urology 1998;33(3):261-70.
1998: Josef Hofbauer; Susanne Fang-Kircher; G Steiner; Helene G Wiener; Martin Susani; R Simak; M A Ghoneim; Michael Marberger
N-acetylneuraminic acids (nana): a potential key in renal calculogenesis.
Urological research 1998;26(1):49-56.
1998: Stephan Madersbacher; Christian Kratzik; Martin Susani; M Pedevilla; Michael Marberger
Transcutaneous high-intensity focused ultrasound and irradiation: an organ-preserving treatment of cancer in a solitary testis.
European urology 1998;33(2):195-201.
1998: Armin Pycha; Christine Mian; Josef Hofbauer; Andrea Haitel; Helene G Wiener; Michael Marberger
Does topical instillation therapy influence chromosomal aberrations in superficial bladder cancer?
The Journal of urology 1998;159(1):265-9.
1998: H Christoph Klingler; Stephan Madersbacher; Bob Djavan; Georg Schatzl; Michael Marberger; CP Schmidbauer
Morbidity of the evaluation of the lower urinary tract with transurethral multichannel pressure-flow studies.
The Journal of urology 1998;159(1):191-4.
1997: Bob Djavan; Alexandre R Zlotta; Martin Susani; G Heinz; S Shariat; DE Silverman; Claude C Schulman; Michael Marberger
Transperineal radiofrequency interstitial tumor ablation of the prostate: correlation of magnetic resonance imaging with histopathologic examination.
Urology 1997;50(6):986-92; discussion 992-3.
1997: Werner J Reiter; Andrea Haitel; Gertraud Heinz-Peer; Armin Pycha; Michael Marberger
Spontaneous nontraumatic rupture of a contracted kidney with subcapsular and perirenal hematoma in a patient receiving chronic hemodialysis.
Urology 1997;50(5):781-3.
1997: Bob Djavan; Stephan Madersbacher; Christoph Klingler; Michael Marberger
Urodynamic assessment of patients with acute urinary retention: is treatment failure after prostatectomy predictable?
The Journal of urology 1997;158(5):1829-33.
1997: Gero Kramer; Georg E Steiner; Stephan Madersbacher; T Stulnig; Thomas Lang; Michael Marberger
Serial tissue polypeptide specific antigen determination in the followup of hormone treated carcinoma of the prostate.
The Journal of urology 1997;158(4):1446-51.
1997: K Dorfinger; Christian Kratzik; Stephan Madersbacher; G Dorfinger; P Berger; Michael Marberger
Tumor markers in hydrocele fluids of patients with benign and malignant scrotal diseases.
The Journal of urology 1997;158(3 Pt 1):851-5.
1997: Stephan Madersbacher; H Christoph Klingler; Bob Djavan; T Stulnig; Georg Schatzl; CP Schmidbauer; Michael Marberger
Is obstruction predictable by clinical evaluation in patients with lower urinary tract symptoms?
British journal of urology 1997;80(1):72-7.
1997: Georg Schatzl; Stephan Madersbacher; Thomas Lang; Michael Marberger
The early postoperative morbidity of transurethral resection of the prostate and of 4 minimally invasive treatment alternatives.
The Journal of urology 1997;158(1):105-10; discussion 110-1.
1997: Armin Pycha; Christine Mian; Andrea Haitel; Josef Hofbauer; Helene G Wiener; Michael Marberger
Fluorescence in situ hybridization identifies more aggressive types of primarily noninvasive (stage pTa) bladder cancer.
The Journal of urology 1997;157(6):2116-9.
1997: Stephan Madersbacher; Christian Kratzik; Michael Marberger
Prostatic tissue ablation by transrectal high intensity focused ultrasound: histological impact and clinical application.
Ultrasonics sonochemistry 1997;4(2):175-9.
1997: Alexandre R Zlotta; Bob Djavan; Michael Marberger; Claude C Schulman
Prostate specific antigen density of the transition zone: a new effective parameter for prostate cancer prediction.
The Journal of urology 1997;157(4):1315-21.
1997: Andrea Haitel; Helene G Wiener; B Migschitz; Michael Marberger; Martin Susani
Proliferating cell nuclear antigen and MIB-1. An alternative to classic prognostic indicators in renal cell carcinomas?
American journal of clinical pathology 1997;107(2):229-35.
1996: S Madersbacher; H Christoph Klingler; Georg Schatzl; Thomas M Stulnig; CP Schmidbauer; Michael Marberger
Age related urodynamic changes in patients with benign prostatic hyperplasia.
The Journal of urology 1996;156(5):1662-7.
1996: Stefan Winkler; S Paiha; H Winkler; Wolfgang Graninger; Michael Marberger; Georg E Steiner
Microfilarial clearance in loiasis involves elevation of Th1 and Th2 products and emergence of a specific pattern of T-cell populations.
Parasite immunology 1996;18(9):479-82.
1996: S Madersbacher; Christoph Klingler; Georg Schatzl; CP Schmidbauer; Michael Marberger
The urodynamic impact of transrectal high-intensity focused ultrasound on bladder outflow obstruction.
European urology 1996;30(4):437-45.
1996: K Höbarth; A Hallas; G Kramer; W Aulitzky; A Gomahr; G Steiner; Michael Marberger
Tissue polypeptide-specific antigen in renal cell carcinoma.
European urology 1996;30(1):89-95.
1996: R Simak; Helene G Wiener; A Foeger; M Susani; Z F Zhang; Ulrich Maier; Michael Marberger
Cytophotometry in the monitoring of bladder cancer under intravesical chemotherapy.
European urology 1996;29(4):391-8.
1996: S Madersbacher; Michael Marberger
[Minimal invasive therapy of benign prostatic hyperplasia].
Wiener medizinische Wochenschrift (1946) 1996;146(8):169-75.
1996: K Höbarth; A Hallas; G Steiner; A Gomahr; W Aulitzky; Michael Marberger
Circulating immune markers in advanced renal cell carcinoma during immunotherapy with interferon gamma.
Urological research 1996;24(2):101-6.
1995: Gero Kramer; G Steiner; D Födinger; Edda Fiebiger; C Rappersberger; S Binder; Josef Hofbauer; Michael Marberger
High expression of a CD38-like molecule in normal prostatic epithelium and its differential loss in benign and malignant disease.
The Journal of urology 1995;154(5):1636-41.
1995: S Madersbacher; M Pedevilla; L Vingers; M Susani; Michael Marberger
Effect of high-intensity focused ultrasound on human prostate cancer in vivo.
Cancer research 1995;55(15):3346-51.
1995: Josef Hofbauer; K Höbarth; Michael Marberger
Electrohydraulic versus pneumatic disintegration in the treatment of ureteral stones: a randomized, prospective trial.
The Journal of urology 1995;153(3 Pt 1):623-5.
1995: S Madersbacher; Christian Kratzik; M Susani; Michael Marberger
[Minimally invasive therapy of benign prostatic hyperplasia with focussed ultrasound].
Der Urologe. Ausg. A 1995;34(2):98-104.
1995: Josef Hofbauer; G Ludvik; M Grbovic; Michael Marberger
[Current status and future developments in noninvasive treatment of urinary calculi with extracorporeal shockwave lithotripsy (ESWL)].
Wiener medizinische Wochenschrift (1946) 1995;145(11-12):254-8.
1995: Michael Marberger
Benign prostatic hyperplasia (BPH) therapy: when? how? why? the take-home message.
Journal d'urologie 1995;101(1):56-7.
1994: S Madersbacher; Christian Kratzik; M Susani; Michael Marberger
Tissue ablation in benign prostatic hyperplasia with high intensity focused ultrasound.
The Journal of urology 1994;152(6 Pt 1):1956-60; discussion 1960-1.
1994: Josef Hofbauer; K Höbarth; N Szabo; Michael Marberger
Alkali citrate prophylaxis in idiopathic recurrent calcium oxalate urolithiasis--a prospective randomized study.
British journal of urology 1994;73(4):362-5.
1994: K Höbarth; N Szabo; A Hallas; W Aulitzky; Michael Marberger
Serum neopterin as a parameter for monitoring the course of renal cell carcinoma during interferon-gamma therapy.
Clinical immunology and immunopathology 1994;70(3):241-4.
1994: G Steiner; Alois Gessl; Gero Kramer; A Schöllhammer; O Förster; Michael Marberger
Phenotype and function of peripheral and prostatic lymphocytes in patients with benign prostatic hyperplasia.
The Journal of urology 1994;151(2):480-4.
1994: Michael Marberger; Josef Hofbauer; C Türk; K Höbarth; Walter Albrecht
Management of ureteric stones.
European urology 1994;25(4):265-72.
1994: D Latal; J Mraz; P Zerhau; M Susani; Michael Marberger
Nitinol urethral stents: long-term results in dogs.
Urological research 1994;22(5):295-300.
1994: Josef Hofbauer; K Höbarth; G Ludvik; Michael Marberger
The 'stone clinic effect': myth or reality?
European urology 1994;26(4):309-13.
1994: S Madersbacher; M Susani; Michael Marberger
Thermal ablation of BPH with transrectal high-intensity focused ultrasound.
Progress in clinical and biological research 1994;386():473-8.
1993: M Eisenmenger; S Lang; G Donner; Christian Kratzik; Michael Marberger
Epidermoid cysts of the testis: organ-preserving surgery following diagnosis by ultrasonography.
British journal of urology 1993;72(6):955-7.
1993: K Höbarth; A Maier; Josef Hofbauer; Michael Marberger
Color flow Doppler sonography for extracorporeal shock wave lithotripsy.
The Journal of urology 1993;150(6):1768-70.
1993: M Susani; S Madersbacher; Christian Kratzik; L Vingers; Michael Marberger
Morphology of tissue destruction induced by focused ultrasound.
European urology 1993;23 Suppl 1():34-8.
1993: Josef Hofbauer; C Tuerk; K Höbarth; R Hasun; Michael Marberger
ESWL in situ or ureteroscopy for ureteric stones?
World journal of urology 1993;11(1):54-8.
1993: S Madersbacher; Christian Kratzik; N Szabo; M Susani; L Vingers; Michael Marberger
Tissue ablation in benign prostatic hyperplasia with high-intensity focused ultrasound.
European urology 1993;23 Suppl 1():39-43.
1993: S Madersbacher; Michael Marberger
[Tissue ablation by high-intensity focused ultrasound in benign prostatic hypertrophy].
Journal d'urologie 1993;99(6):349.
1993: R Simak; M Eisenmenger; A Hainz; Christian Kratzik; Michael Marberger
Is transrectal ultrasonography needed to rule out prostatic cancer with normal findings at digital rectal examination and normal serum prostate-specific antigen?
European urology 1993;24(4):474-8.
1992: F Krings; C Tuerk; I Steinkogler; Michael Marberger
Extracorporeal shock wave lithotripsy retreatment ("stir-up") promotes discharge of persistent caliceal stone fragments after primary extracorporeal shock wave lithotripsy.
The Journal of urology 1992;148(3 Pt 2):1040-1; discussion 1041-2.
1992: Michael Marberger; Josef Hofbauer; C Türk; Walter Albrecht
Management of ureteric calculi (minimally invasive therapy of ureteric stones).
Revue médicale de la Suisse romande 1992;112(9):729-34.
1992: W Hoeltl; Jörg Pont; D Kosak; N Honetz; Michael Marberger
Treatment decision for stage I non-seminomatous germ cell tumours based on the risk factor "vascular invasion".
British journal of urology 1992;69(1):83-7.
1992: K Höbarth; Ulrich Maier; Michael Marberger
Topical chemoprophylaxis of superficial bladder cancer with mitomycin C and adjuvant hyaluronidase.
European urology 1992;21(3):206-10.
1992: K Höbarth; O Zechner; Michael Marberger; Friedrich Herbst; Bela Teleky; R Schiessel
Colorectal cancer involving the urinary tract.
European urology 1992;22(3):213-7.
1992: G Theyer; Gero Kramer; I Assmann; E Sherwood; W Preinfalk; Michael Marberger; O Zechner; Georg E Steiner
Phenotypic characterization of infiltrating leukocytes in benign prostatic hyperplasia.
Laboratory investigation; a journal of technical methods and pathology 1992;66(1):96-107.
1990: Walter Albrecht; C Türk; Michael Marberger
ESWL and endourology on the same table: a feasible concept?
The Journal of lithotripsy & stone disease 1990;2(4):309-17; discussion 318-9.
1990: Wolfgang Höltl; D Kosak; K Probst; Michael Marberger
Incidental carcinoma of the prostate: an improved modality for early detection.
European urology 1990;18(3):184-7.
1989: Michael Marberger; C Türk; I Steinkogler
Piezoelectric extracorporeal shock wave lithotripsy in children.
The Journal of urology 1989;142(2 Pt 1):349-52.
1988: Walter Stackl; R Hasun; Michael Marberger
Intracavernous injection of prostaglandin E1 in impotent men.
The Journal of urology 1988;140(1):66-8.
1988: Michael Marberger; C Türk; I Steinkogler
Painless piezoelectric extracorporeal lithotripsy.
The Journal of urology 1988;139(4):695-9.
1987: W Hoeltl; D Kosak; Jörg Pont; R Hawel; E Machacek; M Schemper; N Honetz; Michael Marberger
Testicular cancer: prognostic implications of vascular invasion.
The Journal of urology 1987;137(4):683-5.